See Exactly Where Your Pharmacy Is Losing Money
IMC Intelligence is a complimentary analytics report — included at no charge for every client using both IMC Inventory Services and IMC Reverse Distribution. It cross-references your outdated returns data against your physical inventory, showing what was credited, what wasn't, and what's headed for the same fate.
Last Inventory Value
$0
Returned for Credit
$0
Wasted — No Credit
$0
Last Inventory Count
Every drug on your shelf — quantity, NDC, and current value
Outdated Returns Data
Every drug returned through reverse distribution — credit status and waste value
IMC Intelligence Report
Inventory vs credited vs uncredited — ranked by financial exposure
Money Flow Analysis
Inventory on Shelf vs. What Was Returned vs. What Was Lost
For every drug in your facility, IMC Intelligence shows three numbers side by side — what you counted on your last inventory, what came back for credit, and what was disposed of with nothing recovered.
24% of total waste value left this facility with zero credit recovered
Financial Exposure Summary
The Numbers That Matter to Your CFO
Every IMC Intelligence report surfaces four critical metrics your pharmacy director needs to act on immediately.
$0
Wasted Without Credit
Drugs disposed of with zero financial recovery
$0
Successfully Credited
Returned through reverse distribution with credit
$0
Current Inventory at Risk
On-shelf value that could follow the same pattern
0%
Inventory Accuracy
IMC-certified technician count accuracy rate
Deep-Dive Report
Every Drug. Every Dollar. Every Signal.
Filter by outcome to see exactly where your facility stands — credited recoveries, uncredited losses, and overstock risk sitting on your shelf right now.
| Drug Name | Last Inventory Value | Returned for Credit | Wasted — No Credit | Total Waste Value | Signal |
|---|---|---|---|---|---|
Keytruda pembrolizumab | $15,006 | $38,264 | $12,755 | $51,019 | PRIORITY |
Gamunex-C immune globulin | $14,725 | $11,030 | $3,653 | $14,683 | PRIORITY |
Ibrance palbociclib | $34,561 | $8,200 | $2,714 | $10,914 | PRIORITY |
Cerezyme imiglucerase | $762 | $7,448 | $1,862 | $9,310 | PRIORITY |
AquaMEPHYTON phytonadione | $9,277 | $4,771 | $1,193 | $5,964 | PRIORITY |
Eliquis apixaban | $442 | $1,935 | $483 | $2,418 | MONITOR |
Solu-Medrol methylprednisolone | $3,617 | $1,062 | $266 | $1,328 | MONITOR |
Taxol paclitaxel | $3,041 | $1,029 | $257 | $1,286 | MONITOR |
| Totals | $81,431 | $73,739 | $23,183 | $96,922 |
Already an IMC Client? This Report Is Yours.
IMC Intelligence is complimentary — automatically included for every facility that uses both IMC Inventory Services and IMC Reverse Distribution. No add-on fee. No separate engagement. Just the most complete financial picture of your pharmacy's drug spend, delivered with every inventory cycle.
You know what's on your shelf. You don't know what left without credit.
Add IMC Reverse Distribution and your next inventory count automatically becomes an Intelligence Report — at no additional cost. See every drug category where you're losing money on the returns side.
Add Reverse DistributionYou know what you returned. You don't know what's still building up on the shelf.
Add IMC Inventory Services and we cross-reference your waste manifest against your current stock — flagging overstock patterns before they become your next waste cycle. Included free when you use both services.
Add Inventory ServicesAlready using both? Your Intelligence Report is waiting.
If your facility uses IMC for both inventory counts and reverse distribution, IMC Intelligence is already included in your service. Contact us to activate your report at your next inventory cycle — no additional cost.
Activate Your ReportYour Intelligence Report Is Already Included.
If you use IMC for both inventory counts and reverse distribution, IMC Intelligence is complimentary — no extra cost, no separate engagement. Contact us to activate it at your next cycle.